Typharm
Private Company
Funding information not available
Overview
Typharm Group is a long-established, privately-held UK pharmaceutical company with a diversified business model encompassing generic drug manufacturing, contract packaging, and community pharmacy operations. With over 40 years of experience under its current family ownership, the company focuses on delivering cost-effective, essential medicines in areas like dermatology, wound care, and digestive health. Led by Managing Director and practicing pharmacist Chandra Ondhia, Typharm leverages its MHRA-accredited manufacturing and packaging facilities to serve both domestic and international markets. The company's strategy is built on a foundation of operational integrity, patient safety, and partnerships within the healthcare ecosystem.
Technology Platform
Integrated pharmaceutical manufacturing, formulation, and MHRA-accredited contract packaging infrastructure for generic and OTC medicines.
Opportunities
Risk Factors
Competitive Landscape
Typharm competes in the crowded generic pharmaceutical market against large multinational generics firms (e.g., Teva, Sandoz, Viatris) and other UK-focused generic manufacturers. In contract packaging, it competes with specialized CDMOs (Contract Development and Manufacturing Organizations). Its community pharmacy chain operates in a competitive UK retail pharmacy sector dominated by large chains like Boots and independent pharmacies.